TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32384703

Group type: EXPERIMENTAL
Intervention: Yield-mapping system using RGB-D stereovision camera and GNSS receiver
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diameter estimation function
Number of subjects: 40
Study: 36189471

Group type: EXPERIMENTAL
Intervention: Double Bundle ACL reconstruction
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Single Bundle ACL reconstruction
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Single Bundle with Lateral Plasty ACL reconstruction
Number of subjects: 59

Group type: COMPARATOR
Intervention: Patients with irreparable medial meniscal tear
Number of subjects: 59

Group type: COMPARATOR
Intervention: Patients who underwent lateral meniscectomy
Number of subjects: 59

Group type: COMPARATOR
Intervention: Patients with reparable meniscal tear
Number of subjects: 59
Study: 33368499

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg/day
Number of subjects: 60
Study: 33991999

Group type: EXPERIMENTAL
Intervention: VPA140 (140mg/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: VPA30 (30mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: VPA140 (140mg/kg) in injured patient
Number of subjects: 6
Study: 35050817

Group type: EXPERIMENTAL
Intervention: Lateral extra-articular tenodesis (LET)
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Increased graft diameter
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Greater posterior tibial slope
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Preoperative high-grade knee laxity
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Earlier return to sport
Number of subjects: 568
Study: 34129719

Group type: EXPERIMENTAL
Intervention: Injectable fillers in male cheeks (inferiomedial placement)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Injectable fillers in female cheeks (superolateral placement)
Number of subjects: 200
Study: 32564804

Group type: EXPERIMENTAL
Intervention: Mailed fecal immunochemical test outreach plus reminder calls (n=61)
Number of subjects: 782

Group type: EXPERIMENTAL
Intervention: Mailed invitation to screen and reminder phone calls (n=261)
Number of subjects: 782

Group type: COMPARATOR
Intervention: Usual opportunistic screening during a healthcare visit (n=260)
Number of subjects: 782
Study: 34853915

Group type: EXPERIMENTAL
Intervention: 4% articaine single buccal infiltration
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2% lidocaine routine buccal and palatal injections
Number of subjects: 30
Study: 32006028

Group type: COMPARATOR
Intervention: Lipid-based nutrient supplementation (LNS) for children aged 6-18 months (T2)
Number of subjects: 3561

Group type: COMPARATOR
Intervention: Lipid-based nutrient supplementation (LNS) for pregnant/lactating women (T3)
Number of subjects: 3561

Group type: COMPARATOR
Intervention: Control group (T0)
Number of subjects: 3561

Group type: COMPARATOR
Intervention: Parenting messages (T4)
Number of subjects: 3561
Study: 36192565

Group type: EXPERIMENTAL
Intervention: Aceclofenac controlled-release (CR) 200 mg once-a-day for 4 weeks
Number of subjects: 14543
Study: 33656561

Group type: EXPERIMENTAL
Intervention: Contingency management intervention with incentives for submitting a urine sample indicating alcohol abstinence for 12 weeks.
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group with incentives for submitting a urine sample without the requirement of alcohol abstinence for 12 weeks.
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Contingency management intervention
Number of subjects: 158
Study: 32792449

Group type: EXPERIMENTAL
Intervention: Musculoskeletal physiotherapy combined with occlusal splint and education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Occlusal splint and education alone
Number of subjects: 0
Study: 35961278

Group type: EXPERIMENTAL
Intervention: 2000 µg/wk of vitamin B12 supplementation for 90 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline levels of holotranscobalamin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline levels of homocysteine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of VE-cadherin levels between VEG women and VEG men
Number of subjects: 0
Study: 34952856

Group type: EXPERIMENTAL
Intervention: Cash or food transfers (US$11/month) for 6 months contingent on timely attendance
Number of subjects: 800

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 800
Study: 32777376

Group type: EXPERIMENTAL
Intervention: Scleral-sutured enVista MX60 IOLs with postoperative fractures
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Scleral-sutured enVista MX60 IOLs with intraoperative fractures
Number of subjects: 23

Group type: COMPARATOR
Intervention: Postoperative fractures
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Suture materials used
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Time until postoperative fracture
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Repeat displacements
Number of subjects: 23
Study: 35774519

Group type: EXPERIMENTAL
Intervention: Yupingfeng (YPF) granules
Number of subjects: 351

Group type: COMPARATOR
Intervention: pidotimod
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study: 33025051

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg)
Number of subjects: 12
Study: 36349887

Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 1362
Study: 33676007

Group type: EXPERIMENTAL
Intervention: Full ERAS program
Number of subjects: 144

Group type: COMPARATOR
Intervention: Limited ERAS management
Number of subjects: 144
Study: 32424486

Group type: COMPARATOR
Intervention: Continuous basal infusion of 0.15% levobupivacaine at 3 ml/h (group C)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Programmed intermittent boluses of local anesthetic (12 ml every 4 h) (group PIB)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (C and PIB)
Number of subjects: 50
Study: 35118795

Group type: EXPERIMENTAL
Intervention: mi. spot (online intervention)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 41
Study: 32435967

Group type: EXPERIMENTAL
Intervention: Dietary intervention to increase dietary intake during chemotherapy
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Very low protein intake (< 0.8 g kg-1 day-1) before chemotherapy
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: 5.0-9.9% weight loss before chemotherapy
Number of subjects: 155
Study: 36858059

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) with a reduced dose of 60 Gy and concurrent weekly cisplatin in N+ patients
Number of subjects: 61

Group type: COMPARATOR
Intervention: Trans-oral surgery (TOS) and neck dissection (ND) with adjuvant reduced-dose RT depending on pathologic findings
Number of subjects: 61
Study: 34452610

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided single popliteal sciatic nerve block
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no ultrasound-guided single popliteal sciatic nerve block)
Number of subjects: 120
Study: 36151017

Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 118

Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 118
Study: 32142578

Group type: EXPERIMENTAL
Intervention: Guided Bone Regeneration (GBR) procedure
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (implants placed in native bone)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both groups (GBR and control)
Number of subjects: 45
Study: 33966345

Group type: EXPERIMENTAL
Intervention: F-MRP supplementation for 8 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32938468

Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiation therapy (IMRT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Three-dimensional conformal radiotherapy (3D-CRT)
Number of subjects: 60
Study: 34309223

Group type: EXPERIMENTAL
Intervention: Standardized CARTs-defined CAN
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: SDNN
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: rMSSD
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Combination of SDNN and rMSSD
Number of subjects: 311
Study: 33472241

Group type: EXPERIMENTAL
Intervention: Intact-umbilical cord milking (I-UCM)
Number of subjects: 587

Group type: COMPARATOR
Intervention: Cut-umbilical cord milking (C-UCM)
Number of subjects: 587

Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 587
Study: 35931908

Group type: EXPERIMENTAL
Intervention: Intervention arm (physicians completed a 2-h online course in SDM communication skills and received electronic reminders)
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Intervention arm
Number of subjects: 466

Group type: COMPARATOR
Intervention: Comparator arm (received reminders only)
Number of subjects: 466
Study: 32978014

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) with external beam radiotherapy (EBRT) to the prostate
Number of subjects: 432

Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) alone
Number of subjects: 432
Study: 35226531

Group type: EXPERIMENTAL
Intervention: 12 mg of dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: 6 mg of dexamethasone
Number of subjects: 0
Study: 33720065

Group type: COMPARATOR
Intervention: PEEP 3 cmH2O
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PEEP 6 cmH2O
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PEEP 9 cmH2O
Number of subjects: 0
Study: 32819864

Group type: EXPERIMENTAL
Intervention: Kinesiotherapy treatment protocol (KTP)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Amitriptyline alone (control)
Number of subjects: 57
Study: 33988708

Group type: EXPERIMENTAL
Intervention: Flotation-REST intervention (5 sessions, 60-90 minutes each, separated by 4 days)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo treatment (5 sessions, 60-90 minutes each, separated by 4 days)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Wait-list control (no additional treatment)
Number of subjects: 99
Study: 32862667

Group type: EXPERIMENTAL
Intervention: Colchicine (0.5 mg twice daily for the first month, then 0.5 mg daily for 11 months)
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 795

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 795
Study: 35112520

Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ropinirole
Number of subjects: 44
Study: 32959590

Group type: EXPERIMENTAL
Intervention: Fire needling bloodletting, applied twice a week for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Operation
Number of subjects: 60
Study: 35235856

Group type: EXPERIMENTAL
Intervention: Psychosocial pain management intervention
Number of subjects: 0
Study: 33063576

Group type: EXPERIMENTAL
Intervention: Child Posture Variability Coding (CPVC)
Number of subjects: 10
Study: 32701843

Group type: EXPERIMENTAL
Intervention: MBSR+
Number of subjects: 98

Group type: COMPARATOR
Intervention: SMH
Number of subjects: 98
Study: 34325037

Group type: EXPERIMENTAL
Intervention: Very early mobilisation after stroke
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: No previous diabetes
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Lower stroke severity
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Less 3-month depressive traits (IDA scale)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Less 3-month disability (modified Rankin Scale)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Prior full-time work
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Younger age (multivariable analysis)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Lower stroke severity (multivariable analysis)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Prior full-time work (multivariable analysis)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Less 3-month disability (multivariable analysis)
Number of subjects: 376
Study: 32921545

Group type: EXPERIMENTAL
Intervention: Post-operative management without drainage tube placement
Number of subjects: 42

Group type: COMPARATOR
Intervention: Post-operative management with drainage tube placement
Number of subjects: 42
Study: 35670414

Group type: EXPERIMENTAL
Intervention: Single-dose ceftriaxone (1 g) and metronidazole (500 mg) 30–60 min before incision
Number of subjects: 162

Group type: COMPARATOR
Intervention: Multiple-dose ceftriaxone and metronidazole followed by cefuroxime and metronidazole for 5 days
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Single-dose ceftriaxone and metronidazole
Number of subjects: 162
Study: 33168657

Group type: EXPERIMENTAL
Intervention: Alpelisib plus Fulvestrant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus Fulvestrant
Number of subjects: 0
Study: 34015478

Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 5674

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5674
Study: 32519782

Group type: EXPERIMENTAL
Intervention: DAA group (509 patients who achieved sustained virological response after DAA therapy)
Number of subjects: 719

Group type: COMPARATOR
Intervention: Non‐DAA group (210 patients who did not receive DAAs)
Number of subjects: 719
Study: 34744156

Group type: EXPERIMENTAL
Intervention: Etco2 levels 40 mm Hg or higher (group H)
Number of subjects: 90
Study: 33429127

Group type: EXPERIMENTAL
Intervention: Terazosin quantification using LC-MS/MS method
Number of subjects: 935
Study: 32662862

Group type: EXPERIMENTAL
Intervention: DHA supplementation (1.2 g/d from randomization to 36 weeks' postmenstrual age)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 528
Study: 35024838

Group type: EXPERIMENTAL
Intervention: Fosfomycin (4 g every 6 hours)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Ceftriaxone or meropenem (if resistant)
Number of subjects: 161
Study: 33835939

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: 300 mg SNF472
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: 600 mg SNF472
Number of subjects: 274
Study: 34561142

Group type: EXPERIMENTAL
Intervention: Hepa-B vaccine
Number of subjects: 158

Group type: COMPARATOR
Intervention: Engerix-B vaccine
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 158
Study: 34968694

Group type: EXPERIMENTAL
Intervention: Press-fit short humeral stems
Number of subjects: 41

Group type: COMPARATOR
Intervention: Cemented standard-length humeral stems
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 41
Study: 34506317

Group type: EXPERIMENTAL
Intervention: Participation in the BEST-CLI trial (number of sites in the region)
Number of subjects: 9231909

Group type: COMPARATOR
Intervention: Regional amputation rates per 1000 CLI patients
Number of subjects: 9231909
Study: 32291261

Group type: EXPERIMENTAL
Intervention: Manuscripts published in ICMJE member journals
Number of subjects: 10500

Group type: EXPERIMENTAL
Intervention: Published trials in ICMJE member journals
Number of subjects: 10500

Group type: EXPERIMENTAL
Intervention: Trials registered retrospectively within a year of submission
Number of subjects: 10500

Group type: EXPERIMENTAL
Intervention: Retrospective registrations within the first three to eight weeks after enrolment
Number of subjects: 10500

Group type: EXPERIMENTAL
Intervention: 286 RCTs registered retrospectively in ICMJE member journals
Number of subjects: 10500
Study: 36348280

Group type: EXPERIMENTAL
Intervention: CRANIUM intervention (preventive care screening intervention)
Number of subjects: 536

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 536
Study: 34020737

Group type: EXPERIMENTAL
Intervention: Oral motor intervention (OMI)
Number of subjects: 112
Study: 32690067

Group type: EXPERIMENTAL
Intervention: Extensive cognitive rehabilitation program (comprehensive training including psycho-education, fatigue management, and cognitive strategy training with individual guidance)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Basic cognitive rehabilitation program (brief cognitive training including psycho-education and fatigue management without individual guidance)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Both intervention groups (basic and extensive)
Number of subjects: 261
Study: 36041848

Group type: EXPERIMENTAL
Intervention: 6-month text message-based CME intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future 9-month national program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Full 10-year scaled-up program
Number of subjects: 0
Study: 33427884

Group type: EXPERIMENTAL
Intervention: Surgical treatment performed by Associate Clinicians (ACs)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Surgical treatment performed by Medical Doctors (MDs)
Number of subjects: 230
Study: 33591142

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway LMA‐Supreme™ (LMAS) placement with neuromuscular blocking agents (NMBAs)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway LMA‐Supreme™ (LMAS) placement without neuromuscular blocking agents (NMBAs)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway LMA‐Supreme™ (LMAS) placement with Mallampati III‐IV
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway LMA‐Supreme™ (LMAS) placement with inter‐incisor distance < 3 cm
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway LMA‐Supreme™ (LMAS) placement with reduced neck mobility
Number of subjects: 432
Study: 34564706

Group type: EXPERIMENTAL
Intervention: Coffee consumption (more than 14 cups per week) in rapid metabolizers
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Coffee consumption
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High coffee consumption
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: CYP1A2 rs762551 polymorphism
Number of subjects: 18
Study: 32907390

Group type: EXPERIMENTAL
Intervention: IOP at 6 AM in POAG group
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: ∆IOP in POAG group
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: IOP at 6 AM in GS group
Number of subjects: 65
Study: 36095067

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33629251

Group type: EXPERIMENTAL
Intervention: Chemotherapy regimens (platinum-based therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ongoing and future studies
Number of subjects: 0
Study: 32304159

Group type: EXPERIMENTAL
Intervention: 12-week Accredited Exercise Physiologist-led exercise program
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Partners-in-care perspective
Number of subjects: 59
Study: 35533496

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mycobacterial antigen-specific polyfunctional effector memory Th1 responses at 6-10 weeks
Number of subjects: 0
Study: 33118896

Group type: EXPERIMENTAL
Intervention: Educational programme exploring biodiversity of tomato
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group (usual class activities)
Number of subjects: 136
Study: 36337878

Group type: EXPERIMENTAL
Intervention: Cryoballoon catheter ablation (CA)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Anti-arrhythmic drug (AAD)
Number of subjects: 204
Study: 34663787

Group type: EXPERIMENTAL
Intervention: Problem Solving Therapy
Number of subjects: 249

Group type: COMPARATOR
Intervention: Engage therapy
Number of subjects: 249
Study: 32901826

Group type: EXPERIMENTAL
Intervention: 110 µm cap thickness
Number of subjects: 100

Group type: COMPARATOR
Intervention: 140 µm cap thickness
Number of subjects: 100
Study: 34524097

Group type: EXPERIMENTAL
Intervention: Viewers of 13RW‐3 (intervention group)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Nonviewers of 13RW‐3 (control group)
Number of subjects: 157
Study: 32334980

Group type: EXPERIMENTAL
Intervention: Low-powered convex lenses (+0.50D, +0.75D, +1.25D)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-powered convex lenses (+0.50D and +0.75D)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plano lenses (control)
Number of subjects: 0
Study: 35666376

Group type: EXPERIMENTAL
Intervention: App‐based food‐specific inhibitory control training
Number of subjects: 94

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 94
Study: 34528994

Group type: EXPERIMENTAL
Intervention: Telephone educational intervention on breastfeeding self-efficacy
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 240
Study: 36335517

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg/d)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 169
Study: 34187532

Group type: EXPERIMENTAL
Intervention: Corpuls CPR
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Physio-Control LUCAS 3
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Schiller Easy Pulse
Number of subjects: 19

Group type: COMPARATOR
Intervention: LUCAS 3
Number of subjects: 19
Study: 32350686

Group type: EXPERIMENTAL
Intervention: Chloroquine, Hydroxychloroquine, Lopinavir/Ritonavir, Remdesivir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other potential drugs
Number of subjects: 0
Study: 35103022

Group type: EXPERIMENTAL
Intervention: Group Cognitive-Behavioral Therapy with Interoceptive Exposure (GCBT-IE)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Waiting List (WL)
Number of subjects: 114
Study: 34689673

Group type: EXPERIMENTAL
Intervention: Dynamic norm messages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Static norm messages
Number of subjects: 0

Group type: COMPARATOR
Intervention: No messages (control)
Number of subjects: 0